New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
09:14 EDTNPSP, PBYI, CYTK, ARIA, OMER, PCYC, VTR, HCT, PL, Z, BRCM, SHPG, MTZOn The Fly: Pre-market Movers
HIGHER: NPS Pharmaceuticals (NPSP), up 21% after the Times of London reported that Shire (SHPG) secured a $5B credit facility led by Citigroup (C) for a takeover offer for the company... Broadcom (BRCM), up 15% after saying it will explore strategic alternatives for cellular baseband business, backing Q2 revenue expectations... Protective Life (PL) rises 17% after Dai-ichi Life Insurance reported to be in talks to buy the company... American Realty Capital (HCT) up 10% after Ventas (VTR) agreed to acquire the company for $2.6B in stock and cash. Ventas shares down 1.8% in pre-market trade following the deal announcement... Conn's (CONN), up 10% after reporting better than expected Q1 earnings results... ARIAD (ARIA), up 13.5% after FDA lifts partial clinical hold on Iclusig study. LOWER: MasTec (MTZ), down 13% after lowering its Q2 EPS view... Puma Biotechnology (PBYI), down 16% after presentation of PB272 Phase II data... Cytokinetics falls 8.8% after announcing further results from BENEFIT-ALS trial... Zillow (Z), down 4% after shares downgraded at Pacific Crest and at RBC Capital.
News For NPSP;SHPG;BRCM;Z;PL;HCT;VTR;PCYC;OMER;ARIA;CYTK;PBYI;MTZ From The Last 14 Days
Check below for free stories on NPSP;SHPG;BRCM;Z;PL;HCT;VTR;PCYC;OMER;ARIA;CYTK;PBYI;MTZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 10, 2014
12:24 EDTPCYCPharmacyclics VA contract not likely to change estimates, says RBC Capital
Subscribe for More Information
11:48 EDTNPSPStocks with call strike movement; GTAT NPSP
GT Advanced (GTAT) March 15 call option implied volatility decreased 6% to 39, NPS Pharmaceuticals (NPSP) January 35 call option implied volatility decreased 17% to 60 according to IVolatility.
11:11 EDTNPSPNPS Pharmaceuticals management to meet with Needham
Meetings to be held in Chicago on September 16 and in Kansas City/Minneapolis on September 17 hosted by Needham.
10:58 EDTPCYCPharmacyclics rises after VA contract award revealed
Shares of drugmaker Pharmacyclics are rising after a contract for its Imbruvica drug that was previously awarded by the Department of Veterans Affairs was disclosed. The contract, which has an award date of September 4, was revealed in an award notice posted today today to Federal Business Opportunities website and has a potential value of $3.809B, according to the posting. Pharmacyclics shares are up 6.5% to $126.35 in morning trading following the circulation of the FBO site posting.
10:51 EDTPCYCPharmacyclics receives contract up to $3B from Department of Veterans Affairs
Subscribe for More Information
10:51 EDTNPSPNPS briefing docs more favorable than expected, says FBR Capital
Subscribe for More Information
10:48 EDTNPSPNPS briefing docs 'much less negative' than feared, says Leerink
Subscribe for More Information
10:36 EDTNPSPNPS Pharmaceuticals briefing docs for Naptara benign, says Canaccord
Subscribe for More Information
08:37 EDTSHPGMedgenics appoints Scott Applebaum as Chief Legal Officer
Subscribe for More Information
08:27 EDTNPSPNPS Pharmaceuticals rises after FDA briefing materials posted
Subscribe for More Information
08:12 EDTBRCMApple iPhone 802.11ac support a positve for Broadcom, says Macquarie
Subscribe for More Information
08:06 EDTNPSPNPS says FDA posts briefing materials for meeting reviewing Natpara
Subscribe for More Information
07:06 EDTSHPGSangamo plans to submit IND application for hemophilia B in 2Q15
Sangamo BioSciences (SGMO) plans to submit an Investigational New Drug application for the treatment of hemophilia B in Q2 2015. This program, partnered with Shire (SHPG), is the first therapeutic application of Sangamo's zinc finger nuclease-mediated In Vivo Protein Replacement Platform. Sangamo is developing the IVPRP as a generally applicable strategy to provide a one-time, permanent genetic cure for monogenic diseases that are currently managed by protein replacement therapy, which involves costly repeat infusions over the lifetime of the patient.
September 9, 2014
15:13 EDTNPSPNPS Pharmaceuticals September volatility elevated into PDUFA
Subscribe for More Information
11:17 EDTVTRHigh option volume stocks
Subscribe for More Information
08:17 EDTNPSPNPS Pharmaceuticals likely volatile on briefing docs, says FBR Capital
Subscribe for More Information
September 8, 2014
16:47 EDTZFCC review of Zillow-Trulia deal may depend on advertising, WSJ says
The proposed Zillow (Z), Trulia (TRLA) transaction which is currently being reviewed by the Federal Trade Commission may raise concerns at the commission depending on whether the agency views all real-estate advertising equally or instead distinguishes between online ads and those outside cyberspace, says the Wall Street Journal. Reference Link
14:37 EDTNPSPNPS Pharmaceuticals September volatility elevated into PDUFA
Subscribe for More Information
11:51 EDTZZillow, Trulia move lower ahead of short-seller presentation
Subscribe for More Information
11:05 EDTNPSPOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use